Speaker(s): 

Samuel Gidding, MD, Geisinger - has the following disclosure: Esperion-consultant/advisor.

Matt Nelson, DO, General Pediatrics, Woodbine, Geisinger-has nothing to disclose

Moderator(s): 

 Frank Maffei, MD, Chair or Pediatrics, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Provide an update on the Familial Hypercholesterolemia literature over the last three years
• Present the results of the CAREFH study to improve pediatric lipid screening
• Discuss next steps in FH recognition and treatment

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Frank Maffei, MD, Amy Diehl, BSN, RN, CPN, Joan Keehan, RPH, Sandra Heller, and Connie Winter have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose: Rebecca Boop, DNP, RN, Robert Cooney, MD, MSMedEd, FACEP

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None